Literature DB >> 11908259

Nitrofurantoin-induced chronic active hepatitis.

Guy Amit1, Patrizia Cohen, Zvi Ackerman.   

Abstract

BACKGROUND: Nitrofurantoin is a commonly prescribed urinary antiseptic. Hepatic injury has been associated with its use.
OBJECTIVES: To present three patients in whom long-term exposure to the drug resulted in chronic active hepatitis; and to review the epidemiology, clinical immunology, histopathology, pathogenetic features and treatment of previously reported cases.
RESULTS: Withdrawing nitrofurantoin once the diagnosis was suspected did not lead to remission of the liver disease and glucocorticoids had to be administered. One patient died of liver failure.
CONCLUSIONS: Awareness of this unusual side effect of nitrofurantoin is important and caution should be taken before prescribing it. Over the past years new insight into the immune nature of this drug has emerged.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908259

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  5 in total

1.  Nitrofurantoin-associated lung and liver toxicity leading to liver transplantation in a middle-aged patient.

Authors:  Tony K L Kiang; Jo-Ann Ford; Eric M Yoshida; Nilufar Partovi
Journal:  Can J Hosp Pharm       Date:  2011-07

Review 2.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 3.  Drug-induced autoimmune-like hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.487

4.  Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease.

Authors:  Jagannath M Sherigar; Richard Fazio; Minsheng Zuang; Edward Arsura
Journal:  Clin Pract       Date:  2012-10-17

5.  Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.

Authors:  Einar S Björnsson; Inmaculada Medina-Caliz; Raul J Andrade; M Isabel Lucena
Journal:  Hepatol Commun       Date:  2022-05-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.